InsiderTrades

Form 4 for ZBH Zimmer Biomet

Accepted 2022-07-06 00:00:00 ET · period of report 2022-07-01 · accession 0001062993-22-016063 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-07-06 2022-07-05 ZBH VAN ZUILEN WILFRED Pres, Europe, M. East, Africa S - Sale+OE $105.22 -531 2,240 -19% -$55.9K
D 2022-07-06 2022-07-01 ZBH VAN ZUILEN WILFRED Pres, Europe, M. East, Africa M - OptEx $0.00 +2,633 2,771 +1,908% $0
D 2022-07-06 2022-07-01 ZBH VAN ZUILEN WILFRED Pres, Europe, M. East, Africa M - OptEx $0.00 -2,633 7,897 -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-07-05 S D 531 $105.22 2,240 D — — (F2) The shares were sold to cover taxes associated with the settlement of restricted stock units ("RSUs").
2 Common Common Stock 2022-07-01 M A 2,633 $0.00 2,771 D — — (F1) Includes 138 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan through January 10, 2022.
3 Derivative Restricted Stock Units 2022-07-01 M D 2,633 $0.00 7,897 D $0.00 · — to — 2,633 Common Stock (F4) Amount reflects the adjustments that occurred as of March 1, 2022 in connection with the Company's spinoff of ZimVie Inc. In connection with the spinoff, each outstanding RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit. (F3) Each RSU represents a contingent right to receive one share of the Company's common stock. (F5) 2,633 of the RSUs vested on July 1, 2022 and the remaining 7,897 RSUs are scheduled to vest in thirds on each of July 1, 2023, 2024 and 2025.